GlassScriptPhysician profile
Amanda Prince
NPI 1972078483
$1,389.11
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,283 · 2023: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $223.27 | 2022 | |
| Abbvie INC. | $217.57 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $195.87 | 2022 | |
| Sunovion Pharmaceuticals INC. | $188.84 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $136.81 | 2022-2023 | Abilify Maintena, Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $117.11 | 2022 | |
| Corium, LLC | $60.86 | 2022 | |
| Neurocrine Biosciences, INC. | $49.74 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.82 | 2022 | |
| Lundbeck LLC | $31.37 | 2022-2023 | Rexulti |
| Axsome Therapeutics, INC. | $25.91 | 2022 | |
| Bausch Health US, LLC | $23.03 | 2022 | |
| Indivior INC. | $20.97 | 2022 | |
| Tris Pharma INC | $20.19 | 2022 | |
| Ironshore Pharmaceuticals INC. | $13.55 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $13.47 | 2022 | |
| Avanir Pharmaceuticals, INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.